Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Buy
60
PPTDF Quote, Financials, Valuation and Earnings
Last price:
$17.15
Seasonality move
:
-2.08%
Day range:
$17.15 - $17.15
52-week range:
$8.56 - $18.00
Dividend yield:
0%
P/E ratio:
20.38x
P/S ratio:
7.14x
P/B ratio:
5.43x
Volume:
--
Avg. volume:
85
1-year change:
100.35%
Market cap:
$2.2B
Revenue:
$204.6M
EPS (TTM):
$0.84
Analysts' Opinion
-
Consensus RatingPeptiDream has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, PeptiDream has an estimated downside of -- from its current price of $17.15.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $17.15.
Fair Value
-
According to the consensus of 0 analysts, PeptiDream has -- downside to fair value with a price target of -- per share.
PPTDF vs. S&P 500
-
Over the past 5 trading days, PeptiDream has overperformed the S&P 500 by 2.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
PeptiDream does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PeptiDream revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter PeptiDream reported revenues of $36.8M.
Earnings Growth
-
PeptiDream has grown year-over-year earnings for 1 quarter straight. In the most recent quarter PeptiDream reported earnings per share of -$0.02.
Enterprise value:
2B
EV / Invested capital:
3.65x
Price / LTM sales:
7.14x
EV / EBIT:
12.81x
EV / Revenue:
6.45x
PEG ratio (5yr expected):
0.53x
EV / Free cash flow:
11.73x
Price / Operating cash flow:
12.97x
Enterprise value / EBITDA:
11.67x
Gross Profit (TTM):
$230.3M
Return On Assets:
20.65%
Net Income Margin (TTM):
35.04%
Return On Equity:
34.66%
Return On Invested Capital:
24.02%
Operating Margin:
-2.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $98M | $271.9M | $311.8M | $90.8M | $36.8M | |
| Gross Profit | $48.7M | $189.9M | $230.3M | $71.1M | $17.4M | |
| Operating Income | -$4.6M | $113M | $157M | $53.6M | -$854.5K | |
| EBITDA | $8.2M | $129.8M | $172.3M | $58.5M | $3.1M | |
| Diluted EPS | -$0.01 | $0.61 | $0.84 | $0.23 | -$0.02 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $83.8M | $136.2M | $102.3M | $184.7M | $412.4M | |
| Total Assets | $180M | $249.2M | $354.8M | $442.5M | $654.2M | |
| Current Liabilities | $13.8M | $25.2M | $44.7M | $76.8M | $117.6M | |
| Total Liabilities | $15.3M | $28M | $185.4M | $191.7M | $244.8M | |
| Total Equity | $164.7M | $221.2M | $169.4M | $250.8M | $409.4M | |
| Total Debt | -- | -- | $146M | $126.6M | $142M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.7M | $73.2M | $185.5M | -$309.9K | $177.6M | |
| Cash From Investing | -$200.5M | -$2.4M | $60.5M | $18.1M | -$334.1K | |
| Cash From Financing | $151.7M | -$12.5M | $7.2M | -$3.6M | -$5.6M | |
| Free Cash Flow | -$36.8M | $62.3M | $171.6M | -$2.1M | $173.8M | |
PPTDF
Sector
Market Cap
$2.2B
$43.9M
Price % of 52-Week High
95.28%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
-0.07%
-0.74%
1-Year Price Total Return
100.35%
-29.11%
Beta (5-Year)
0.826
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$17.15
200-day SMA
Buy
Level
$14.21
Bollinger Bands (100)
Buy
Level
15.2 - 17.54
Chaikin Money Flow
Sell
Level
-14.3K
20-day SMA
Buy
Level
$17.06
Relative Strength Index (RSI14)
Buy
Level
96.12
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$17.02
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
80.9K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8371)
Buy
CA Score
(Annual)
Level (0.3224)
Buy
Beneish M-Score
(Annual)
Level (-3.6748)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.455)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
Stock Forecast FAQ
In the current month, PPTDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PPTDF average analyst price target in the past 3 months is --.
-
Where Will PeptiDream Stock Be In 1 Year?
According to analysts, the consensus estimate is that PeptiDream share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PeptiDream?
Analysts are divided on their view about PeptiDream share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PeptiDream is a Sell and believe this share price will rise from its current level to --.
-
What Is PeptiDream's Price Target?
The price target for PeptiDream over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PPTDF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PeptiDream is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PPTDF?
You can purchase shares of PeptiDream via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PeptiDream shares.
-
What Is The PeptiDream Share Price Today?
PeptiDream was last trading at $17.15 per share. This represents the most recent stock quote for PeptiDream. Yesterday, PeptiDream closed at $17.15 per share.
-
How To Buy PeptiDream Stock Online?
In order to purchase PeptiDream stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
